跳至主要内容
临床试验/CTRI/2026/03/107082
CTRI/2026/03/107082尚未招募3 期

Comparative evaluation of peri-implant soft tissue response to graphene reinforced PMMA and PEEK customized healing abutments: A randomized clinical trial.

Dr Damodar Shnabhag1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2026年4月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
22
试验地点
1

研究概览

简要总结

This randomized clinical trial aims to evaluate and compare the peri-implant soft tissue response to graphene-reinforced PMMA and PEEK customized healing abutments placed during second-stage implant surgery. A total of 22 patients undergoing implant therapy will be randomly allocated into two groups. Customized healing abutments will be digitally designed and fabricated using CAD/CAM technology. Peri-implant soft tissue parameters including bleeding on probing, plaque accumulation, probing depth, mucosal thickness, horizontal and vertical soft tissue dimensions, and patient-reported discomfort will be assessed at baseline and 3 weeks after placement. The study intends to generate clinical evidence regarding the soft tissue behavior of graphene-reinforced PMMA compared to PEEK to support material selection in implant prosthodontics.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with the age 18 years and above.
  • Partially Edentulous cases indicated for implant iii.
  • Patient with informed consent willing to participate in the study.

排除标准

  • Patient not indicated for dental implant procedure like a.
  • Patients on anticoagulant, corticosteroid, fibrinolytic and anti-platelet therapy, b.
  • Patients with bleeding disorders c.
  • Patients with debilitating diseases.
  • Patients requiring immediate implant placement following tooth extraction iii.
  • Patients in whom an immediate transmucosal healing abutment was planned to be placed at the time of implant insertion iv.
  • Patients receiving medications that interfere with bone metabolism or soft tissue healing v.
  • Presence of active infection or acute inflammatory pathology at the proposed implant site.
  • Sites requiring extensive guided bone regeneration or major augmentation procedures at the time of implant placement.
  • Pregnant or lactating women, viii.
  • Patients with a history of smoking or tobacco use ix.
  • Patients unable or unwilling to comply with the study protocol, including scheduled follow-up visits, oral hygiene instructions, or postoperative care requirements.

研究者

发起方
Dr Damodar Shnabhag
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Damodar Shanbhag

Rural Dental College, Pravara Institute of Medical Sciences.

研究点 (1)

Loading locations...

相似试验